Jyong Biotech MENS
NASDAQ MENS
$2.18 +0.15 (+7.39%)
At close: Oct 2, 2026 · 4:00 PM EDT

Jyong Biotech (MENS) Land & Improvements (2024 - 2025)

Updated

Jyong Biotech's Land & Improvements was $995,000 in the quarter ended Dec 31, 2025, compared with $952.00 a year earlier.

Analysis

Jyong Biotech (MENS) Land & Improvements (2024 - 2025) Analysis & Trends

  • In earlier years, Land & Improvements was $952.00 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Jyong Biotech 165.74 Mn 165.74 Mn - 995,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 995,000.00
Dec 31, 2024 952.00
API Access

Jyong Biotech Land & Improvements API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=land-and-improvements&ticker=MENS&period=max&api_key=YOUR_API_KEY